A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation

Journal of Clinical Investigation

Volumn 101, Issue 12, 1998, Pages 2900-2909

  DeLeo, Frank R ^a   Goedken, Melissa ^a   McCormick, Sally J ^a   Nauseef, William M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Endoplasmic reticulum; Molecular chaperone; Myeloperoxidase; Polymorphonuclear leukocyte; Proteasome

Indexed keywords

CALNEXIN; CALRETICULIN; CHAPERONE; HEME; MYELOPEROXIDASE; PROTEASOME;

AMINO ACID SUBSTITUTION; ARTICLE; AUTORADIOGRAPHY; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CODON; ENDOPLASMIC RETICULUM; ENZYME DEFICIENCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MISSENSE MUTATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS;

EID: 0032526264     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2649     Document Type: Article

References (36)

1. Klebanoff, S.J. 1970. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science. 169:1095-1097.
2. Klebanoff, S.J., and C.B. Hamon. 1972. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J. Reticuloendothel. Soc. 12: 170-196.
3. Robinson, J.M., and J.A. Badwey. 1995. The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view. Histochemistry. 103:163-180.
4. Hazen, S.L., F.F. Hsu, D.M. Mueller, J.R. Crowley, and J.W. Heinecke. 1996. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98:1283-1289.
5. Hazen, S.L., F.F. Hsu, K. Duffin, and J.W. Heinecke. 1996. Molecular chlorine generated by the myeloperoxidase hydrogen peroxide chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271:23080-23088.
6. Nauseef, W.M., I. Olsson, and K. Arnijots. 1988. Biosynthesis and processing of myeloperoxidase. A marker for myeloid cell differentiation. Eur. J. Haematol. 40:97-110.
7. Nauseef, W.M. 1990. Myeloperoxidase deficiency. Hematol. Pathol. 4: 165-178.
8. Akin, D.T., J.M. Kinkade, Jr., and R.T. Parmley. 1987. Biochemical and ultrastructural effects of monensin on the processing, intracellular transport, and packaging of myeloperoxidase into low and high density compartments of human leukemia (HL-60) cells. Arch. Biochem. Biophys. 257:451-463.
9. Nauseef, W.M., S.J. McCormick, and R.A. Clark. 1995. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J. Biol. Chem. 270:4741-4747.
10. Nauseef, W.M., S.J. McCormick, and M. Goedken. 1998. Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J. Biol. Chem. 273:7101-7111.
11. Nauseef, W.M., M. Cogley, and S. McCormick. 1996. Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J. Biol. Chem. 271:9546-9549.
12. Nauseef, W.M., S. McCormick, and H. Yi. 1992. Roles of home insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysomal enzyme, myeloperoxidase. Blood. 80:2622-2633.
13. Lehrer, R.I., and M.J. Cline. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Invest. 48:1478-1488.
14. Tobler, A.M., E. Selsted, C.W. Miller, K.R. Johnson, M.J. Novotny, G. Rovera, and H.P. Koeffler. 1989. Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency. Blood. 73:1980-1986.
15. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. J. Clin. Lab. Invest. 21:77-89.
16. Nauseef, W.M., S. Brigham, and M. Cogley. 1994. Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan. J. Biol. Chem. 269:1212-1216.
17. Borregaard, N., J.M. Heiple, E.R. Simons, and R.A. Clark. 1983. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J. Cell. Biol. 97:52-61.
18. Sottocasa, G.L., B. Kuylenstierna, L. Ernster, and A. Bergstrand. 1967. An electron transport system associated with the outer membrane of liver mitochondria. J. Cell Biol. 32:415-438.
19. Nauseef, W.M., and R.A. Clark. 1986. Separation and analysis of subcellular organelles in a human promyelocytic leukemia cell line, HL-60: application to the study of myeloid lysosomal enzyme synthesis and processing Blood 68:442-449.
20. Zeng, J., and R.E. Fenna. 1992. X-ray crystal structure of canine myeloperoxidase at 3 A resolution. J. Mol. Biol. 226:185-207.
21. Arnljots, K., and I. Olsson. 1987. Myeloperoxidase precursors incorporate heme. J. Biol. Chem. 262:10430-10434.
22. Hur, S., H. Toda, and M. Yamada. 1989. Isolation and characterization of an unprocessed extracellular myeloperoxidase in HL-60 cell cultures. J. Biol. Chem. 264:8542-8548.
23. Tucker, K.A., M.B. Lilly, L.J. Heck, and T.A. Rado. 1987. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood. 70:372-378.
24. Lozzio, B.B., and C.B. Lozzio. 1979. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leukemia Res. 3:363-370.
25. Jensen, TJ., M.A. Loo, S. Pind, D.B. Williams, A.L. Goldberg, and J. R. Riordan. 1995. Multiple proteolytic systems, including the proteasome contribute to CFTR processing. Cell. 83:129-135.
26. Castaneda, V.L., R.T. Parmley, I.E. Pinnix, S.G. Raju, G.S. Guzman, and J.M. Kinkade, Jr. 1992. Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis. Exp. Hematol. 20:916-924.
27. Pinnix, I.E., G.S. Guzman, H.L. Bonkovsky, S.R. Zaki, and J.M. Kinkade, Jr. 1994. The post-translational processing of myeloperoxidase is regulated by the availability of heme. Arch. Biochem. Biophys. 312:447-458.
28. Ward, C.L., S. Omura, and R.R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 83:121-127.
29. Kopito, R.R. 1997. ER quality control: the cytoplasmic connection. Cell. 88:427-430.
30. Werner, E.D., J.L. Brodsky, and A.A. McCraken. 1996. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar late. Proc. Natl. Acad. Sci. USA. 93:13797-13801.
31. Hiller, M.M., A. Finger, M. Schweiger, and D.H. Wolf, 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science. 273:1725-1728.
32. Ou. W., P.M. Cameron, D.Y. Thomas, and J.J.M. Bergeron. 1993. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature. 364:771-776.
33. Cross, A.R., J.T. Curnutte, J. Rae, and P.G. Heyworth. 1996. Hematologically important mutations: X-linked chronic granulomatous disease. Blood Cells Mol. Dis. 22:90-95.
34. Thrasher, A.J., N.H. Keep, F. Wientjes, and A.W. Segal. 1994. Chronic granulomatous disease. Biochim. Biophys. Acta. 1227:1-24.
35. Wright, A.H., W.A. Douglass, G.M. Taylor, Y.L. Lau, D. Higgins, K.A. Davies, and S.K.A. Law. 1995. Molecular characterization of leukocyte adhesion deficiency in six patients. Eur. J. Biochem. 25:717-722.
36. Nauseef, W.M. 1986. Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: insight into myeloperoxidase deficiency. Blood. 67: 865-872.